Gene · 5009
Papers3,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expanding carrier screening: beyond the genes, to include underrepresented ancestries. | NPJ Genom Med | 2025 | 41453871 | PubTator, text mining | PubMed |
| Establishment and validation of a diagnostic model for cholangiocarcinoma based on LightGBM machine-learning algorithm. | Sci Rep | 2025 | 41331315 | PubTator, text mining | PubMed |
| Early continuous blood purification and timely liver transplantation in a neonatal-onset ornithine transcarbamylase deficiency: a case report. | Transl Pediatr | 2025 | 41216469 | PubTator, text mining | PubMed |
| Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects. | Front Oncol | 2025 | 41179661 | PubTator, text mining | PubMed |
| κ-Opioid receptor activation suppresses triple-negative breast cancer progression by inducing urea cycle dysfunction and mitochondrial damage in vitro and in mice. | Br J Anaesth | 2025 | 41107146 | PubTator, text mining | PubMed |
| Metabolic profiles of squamous cell lung carcinoma and diagnostic model construction. | Sci Rep | 2025 | 41028147 | PubTator, text mining | PubMed |
| Extract of Indigofera spicata Exerts Antiproliferative Effects on Human Colorectal and Ovarian Carcinoma Cells. | Toxins (Basel) | 2025 | 41003496 | PubTator, text mining | PubMed |
| Gastric Bypass Associated Hyperammonemia (GaBHA): A Case Study, Scoping Review of the Literature, and Proposed New Pathophysiologic Mechanism. | Metabolites | 2025 | 41002957 | PubTator, text mining | PubMed |
| Recent advances in interface engineering for photoelectrochemical detection of new pollutants. | Chem Sci | 2025 | 40988684 | PubTator, text mining | PubMed |
| acmgscaler: an R package and Colab for standardized gene-level variant effect score calibration within the ACMG/AMP framework. | Bioinformatics | 2025 | 40929116 | PubTator, text mining | PubMed |
| Optimizing gene prioritization for clinical diagnosis of metabolic genetic disorders. | PLoS One | 2025 | 40880426 | PubTator, text mining | PubMed |
| Metabolic dysregulation in pulmonary fibrosis: insights into amino acid contributions and therapeutic potential. | Cell Death Discov | 2025 | 40858556 | PubTator, text mining | PubMed |
| ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalance. | Hepatol Commun | 2025 | 40824254 | PubTator, text mining | PubMed |
| Boosting energy metabolism and biosynthesis in diverse organisms by a common bacterial salvage lipoylation protein. | Nat Commun | 2025 | 40813772 | PubTator, text mining | PubMed |
| Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma. | J Exp Clin Cancer Res | 2025 | 40813699 | PubTator, text mining | PubMed |
| Clinical characteristics and long-term outcomes of 101 patients with urea cycle disorders in China. | Orphanet J Rare Dis | 2025 | 40804416 | PubTator, text mining | PubMed |
| Urea cycle dysregulation drives metabolic stress and neurodegeneration in Parkinson's disease. | NPJ Parkinsons Dis | 2025 | 40790122 | PubTator, text mining | PubMed |
| Late-onset ornithine transcarbamylase deficiency mimicking cognitive, behavioral and gait disorders: a case report and literature review. | Postep Psychiatr Neurol | 2025 | 40666616 | PubTator, text mining | PubMed |
| Antibiotics re-booted-time to kick back against drug resistance. | NPJ Antimicrob Resist | 2025 | 40447846 | PubTator, text mining | PubMed |
| Mitochondrial calcium signaling regulates branched-chain amino acid catabolism in fibrolamellar carcinoma. | Sci Adv | 2025 | 40435263 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5009/papers?page=3